175 related articles for article (PubMed ID: 28449113)
1. Development of a New Clinical Severity Staging System for Patients With Nonmetastatic Papillary Thyroid Carcinoma.
Karadaghy OA; Kallogjeri D; Piccirillo JF
JAMA Otolaryngol Head Neck Surg; 2017 Dec; 143(12):1173-1180. PubMed ID: 28449113
[TBL] [Abstract][Full Text] [Related]
2. Clinical features of poorly differentiated thyroid papillary carcinoma.
Higashino M; Ayani Y; Terada T; Kurisu Y; Hirose Y; Kawata R
Auris Nasus Larynx; 2019 Jun; 46(3):437-442. PubMed ID: 30466760
[TBL] [Abstract][Full Text] [Related]
3. Appropriateness of the revised Japanese guidelines' risk classification for the prognosis of papillary thyroid carcinoma: a retrospective analysis of 5,845 papillary thyroid carcinoma patients.
Ito Y; Miyauchi A; Oda H; Masuoka H; Higashiyama T; Kihara M; Miya A
Endocr J; 2019 Feb; 66(2):127-134. PubMed ID: 30626761
[TBL] [Abstract][Full Text] [Related]
4. Mortality Risk of Nonoperative Papillary Thyroid Carcinoma: A Corollary for Active Surveillance.
Ho AS; Luu M; Zalt C; Morris LGT; Chen I; Melany M; Ali N; Patio C; Chen Y; Mallen St-Clair J; Braunstein GD; Sacks WL; Zumsteg ZS
Thyroid; 2019 Oct; 29(10):1409-1417. PubMed ID: 31407637
[No Abstract] [Full Text] [Related]
5. Upregulation of the solute carrier family 7 genes is indicative of poor prognosis in papillary thyroid carcinoma.
Shen L; Qian C; Cao H; Wang Z; Luo T; Liang C
World J Surg Oncol; 2018 Dec; 16(1):235. PubMed ID: 30558624
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Parameters in Differentiated Thyroid Carcinomas.
Cipriani NA
Surg Pathol Clin; 2019 Dec; 12(4):883-900. PubMed ID: 31672296
[TBL] [Abstract][Full Text] [Related]
7. Association of Lymph Node Density With Survival of Patients With Papillary Thyroid Cancer.
Amit M; Tam S; Boonsripitayanon M; Cabanillas ME; Busaidy NL; Grubbs EG; Lai SY; Gross ND; Sturgis EM; Zafereo ME
JAMA Otolaryngol Head Neck Surg; 2018 Feb; 144(2):108-114. PubMed ID: 29192312
[TBL] [Abstract][Full Text] [Related]
8. Total vs hemithyroidectomy for intermediate risk papillary thyroid cancer: A 23 year retrospective study in a tertiary center.
Tsui KP; Kwan WY; Chow TL
Am J Otolaryngol; 2019; 40(3):431-434. PubMed ID: 30956005
[TBL] [Abstract][Full Text] [Related]
9. Recurrence following hemithyroidectomy in patients with low- and intermediate-risk papillary thyroid carcinoma.
Ahn D; Lee GJ; Sohn JH
Br J Surg; 2020 May; 107(6):687-694. PubMed ID: 32026467
[TBL] [Abstract][Full Text] [Related]
10. Changes in total thyroidectomy versus thyroid lobectomy for papillary thyroid cancer during the past 15 years.
James BC; Timsina L; Graham R; Angelos P; Haggstrom DA
Surgery; 2019 Jul; 166(1):41-47. PubMed ID: 30904172
[TBL] [Abstract][Full Text] [Related]
11. Modification of the eight-edition tumor-node-metastasis staging system with N1b for papillary thyroid carcinoma: A multi-institutional cohort study.
Kim M; Kim HK; Kim HI; Kim EH; Jeon MJ; Yi HS; Kim ES; Kim H; Kim TH; Kim BH; Kim TY; Kang HC; Kim WB; Chung JH; Shong YK; Kim SW; Kim WG
Oral Oncol; 2018 Nov; 86():48-52. PubMed ID: 30409319
[TBL] [Abstract][Full Text] [Related]
12. The impact of radioactive iodine treatment on survival among papillary thyroid cancer patients according to the 7th and 8th editions of the AJCC/TNM staging system: a SEER-based study.
Liu X; Fan Y; Liu Y; He X; Zheng X; Tan J; Jia Q; Meng Z
Updates Surg; 2020 Sep; 72(3):871-884. PubMed ID: 32342347
[TBL] [Abstract][Full Text] [Related]
13. Recurrence predictability by various staging systems in 283 patients after thyroidectomy and radioactive iodine treated for papillary thyroid carcinoma.
Yaniv D; Mizrachi A; Raz R; Tzelnick S; Feinmesser R; Hamzany Y; Vaisbuch Y; Hilly O
Clin Otolaryngol; 2019 Nov; 44(6):1147-1152. PubMed ID: 31437357
[No Abstract] [Full Text] [Related]
14. Survival in Differentiated Thyroid Cancer: Comparing the AJCC Cancer Staging Seventh and Eighth Editions.
Tam S; Boonsripitayanon M; Amit M; Fellman BM; Li Y; Busaidy NL; Cabanillas ME; Dadu R; Sherman S; Waguespack SG; Williams MD; Goepfert RP; Gross ND; Perrier ND; Sturgis EM; Zafereo ME
Thyroid; 2018 Oct; 28(10):1301-1310. PubMed ID: 30141373
[TBL] [Abstract][Full Text] [Related]
15. Predictors of Neck Reoperation and Mortality After Initial Total Thyroidectomy for Differentiated Thyroid Cancer.
Semrad TJ; Keegan THM; Semrad A; Brunson A; Farwell DG
Thyroid; 2018 Sep; 28(9):1143-1152. PubMed ID: 29929451
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for skip metastasis and lateral lymph node metastasis of papillary thyroid cancer.
Zhao H; Huang T; Li H
Surgery; 2019 Jul; 166(1):55-60. PubMed ID: 30876667
[TBL] [Abstract][Full Text] [Related]
17. Microscopic positive margins strongly predict reduced disease-free survival in pT4a papillary thyroid cancer.
Abraham E; Roshan D; Tran B; Graham S; Lehane C; Wykes J; Campbell P; Ebrahimi A
Head Neck; 2019 Aug; 41(8):2549-2554. PubMed ID: 30860642
[TBL] [Abstract][Full Text] [Related]
18. A novel RNA sequencing-based risk score model to predict papillary thyroid carcinoma recurrence.
He J; Tian Z; Yao X; Yao B; Liu Y; Yang J
Clin Exp Metastasis; 2020 Apr; 37(2):257-267. PubMed ID: 31792675
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Value of Extranodal Tumor Extension in Papillary Thyroid Carcinoma: Proposal for Upstaging of Cases with Extranodal Tumor Extension.
Ito Y; Miyauchi A; Masuoka H; Higashiyama T; Kihara M; Miya A
World J Surg; 2020 Feb; 44(2):638-643. PubMed ID: 31605175
[TBL] [Abstract][Full Text] [Related]
20. Survival of aggressive variants of papillary thyroid carcinoma in patients under 55 years old: a SEER population-based retrospective analysis.
Feng J; Shen F; Cai W; Gan X; Deng X; Xu B
Endocrine; 2018 Sep; 61(3):499-505. PubMed ID: 29909599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
